By Professor Sean Emery

Journal articles

Baker JV; Hullsiek KH; Engen NW; Nelson R; Chetchotisakd P; Gerstoft J; Jessen H; Losso M; Markowitz N; Munderi P; Papadopoulos A; Shuter J; Rappoport C; Pearson MT; Finley E; Babiker A; Emery S; Duprez D; Aagaard B; Borges H; Jansson PO; Neilsen BR; Arenas-Pinto A; Atako NB; Babiker AG; Dennis E; Forcat S; Hudson F; Jackson B; Maas D; Purvis C; Russell C; Carey C; Clewett M; Jacoby S; Sánchez A; Vjecha MJ, 2016, 'Early antiretroviral therapy at high CD4 counts does not improve arterial elasticity: A substudy of the strategic timing of antiretroviral treatment (START) trial', Open Forum Infectious Diseases, 3, pp. ofw213, http://dx.doi.org/10.1093/ofid/ofw213

Murray DD; Suzuki K; Law M; Trebicka J; Neuhaus J; Wentworth D; Johnson M; Vjecha MJ; Kelleher AD; Emery S; Aagaard B; Aragon E; Arnaiz J; Borup L; Clotet B; Dragsted U; Fau A; Gey D; Grarup J; Hengge U; Herrero P; Jansson P; Jensen B; Jensen K; Juncher H; Lopez P; Lundgren JD; Matthews C; Mollerup D; Pearson M; Phillips A; Reilev S; Tillmann K; Varea S; Angus B; Babiker A; Cordwell B; Darbyshire J; Dodds W; Fleck S; Horton J; Hudson F; Moraes Y; Pacciarini F; Palfreeman A; Paton N; Smith N; Van Hooff F; Bebchuk J; Collins G; Denning E; DuChene A; Fosdick L; Harrison M; Herman-Lamin K; Krum E; Larson G; Neaton J; Nelson R; Quan K; Quan S; Schultz T; Thompson G; Wyman N; Carey C; Chan F; Cooper D; Courtney-Rodgers D; Drummond F; Harrod M; Jacoby S; Kearney L; Lin E; Pett S; Robson R; Seneviratne N; Stewart M; Watts E; Finley E; Gordin F; Sánchez A; Standridge B; Belloso W; Davey R; Duprez D; Gatell J; Hoy J; Lifson A; Pederson C; Perez G; Price R; Prineas R; Rhame F; Sampson J; Worley J; Modlin J; Beral V; Chaisson R; Fleming T; Hill C; Bloch M; Cooper D; Konecny P; Carr A; Medland N; Sullivan J; Han A, 2015, 'Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection: A case control study', PLoS ONE, 10, pp. e0139981, http://dx.doi.org/10.1371/journal.pone.0139981

Amin J; Boyd MA; Kumarasamy N; Moore CL; Losso MH; Nwizu CA; Mohapi L; Kerr SJ; Sohn AH; Teppler H; Renjifo B; Molina JM; Emery S; Cooper DA, 2015, 'Erratum: Raltegravir Non-Inferior to Nucleoside Based Regimens in SECOND-LINE Therapy with Lopinavir/Ritonavir over 96 Weeks: A Randomised Open Label Study for the Treatment Of HIV-1 Infection (PLoS ONE (2015)10:2 (e0118228) Doi: 10.1371/journal.pone.0118228 ))', PLoS ONE, 10, pp. e0140623, http://dx.doi.org/10.1371/journal.pone.0140623

Dickinson L; Amin J; Else L; Boffito M; Egan D; Owen A; Khoo S; Back D; Orrell C; Clarke A; Losso M; Phanuphak P; Carey D; Cooper DA; Emery S; Puls R, 2015, 'Pharmacokinetic and Pharmacodynamic Comparison of Once-Daily Efavirenz (400 mg vs. 600 mg) in Treatment-Naive HIV-Infected Patients: Results of the ENCORE1 Study', Clinical Pharmacology and Therapeutics, 98, pp. 406 - 416, http://dx.doi.org/10.1002/cpt.156

Lundgren JD; Babiker AG; Gordin F; Emery S; Grund B; Sharma S; Avihingsanon A; Cooper DA; Fätkenheuer G; Llibre JM; Molina JM; Munderi P; Schechter M; Wood R; Klingman KL; Collins S; Clifford Lane H; Phillips AN; Neaton JD; Kelleher A; Cysique L, 2015, 'Initiation of antiretroviral therapy in early asymptomatic HIV infection', New England Journal of Medicine, 373, pp. 795 - 807, http://dx.doi.org/10.1056/NEJMoa1506816

Borges ÁH; O'Connor JL; Phillips AN; Rönsholt FF; Pett S; Vjecha MJ; French MA; Lundgren JD, 2015, 'Factors Associated with Plasma IL-6 Levels during HIV Infection', Journal of Infectious Diseases, 212, pp. 585 - 595, http://dx.doi.org/10.1093/infdis/jiv123

Amin J; Becker S; Belloso W; Boffito M; Cooper D; Crabtree-Ramirez B; Duncombe C; Foulkes S; Hill A; Jessen H; Kumar S; Lee MP; Nwizu C; Read T; Rooney J; Schaffer K; Shahar E; Winston A; Wolff M; Young B; Abela C; Avihingsanon A; Boyd M; Carey D; Clarke A; Courtney-Vega K; Delfino M; Donaldson A; Emery S; Espinosa N; Johannesen T; Lin E; Losso M; Moricz A; Pett S; Phanupak P; Puls R; Pussadee K; Sutheerasak P; Tomlins L; Ubolyam S; bin Raja Azwa RIS; Bissio E; Calanni L; Chetchotisakd P; Doong N; Elliott J; Gazzard B; Kelly M; Laplume H; del Carmen Luna N; Lupo S; Messina OG; Mohapi L; Moore R; Nolan D; Orrell C; Perez C; Phanuphak P; Rockstroh J; Rowling D; Supparatpinyo K; Smith D; Villanueva JA; Vlahakis E; Kelleher T; Cunningham P; Merlin K; Yeung J; Shaik A; Fsadni B; Carrera A; Lograsso M; Gulick R; Dunn D; Dolan M; Emery S; Kelleher A, 2015, 'Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study', The Lancet Infectious Diseases, 15, pp. 793 - 802, http://dx.doi.org/10.1016/S1473-3099(15)70060-5

Hey-Cunningham WJ; Murray JM; Natarajan V; Amin J; Moore CL; Emery S; Cooper DA; Zaunders J; Kelleher AD; Koelsch KK; PINT study team ; Danta M, 2015, 'Early antiretroviral therapy with raltegravir generates sustained reductions in HIV reservoirs but not lower T-cell activation levels.', AIDS, 29, pp. 911 - 919, http://dx.doi.org/10.1097/QAD.0000000000000625

McFadden E; Bashir S; Canham S; Darbyshire J; Davidson P; Day S; Emery S; Pater J; Rudkin S; Stead M; Brown J, 2015, 'The impact of registration of clinical trials units: The UK experience', Clinical Trials, 12, pp. 166 - 173, http://dx.doi.org/10.1177/1740774514561242

Berthon-Jones N; Courtney-Vega K; Donaldson A; Haskelberg H; Emery S; Puls R, 2015, 'Assessing site performance in the Altair study, a multinational clinical trial', Trials, 16, http://dx.doi.org/10.1186/s13063-015-0653-x

Soliman E; Sharma S; Arastéh K; Wohl D; Achhra A; Tambussi G; O'Connor J; Stein J; Duprez D; Neaton J; Phillips A, 2015, 'Baseline cardiovascular risk in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial', HIV Medicine, 16, pp. 46 - 54, http://dx.doi.org/10.1111/hiv.12233

Winston A; Amin J; Clarke A; Else L; Amara A; Owen A; Barber T; Jessen H; Avinghsanon A; Chetchotisakd P; Khoo S; Cooper DA; Emery S; Puls R; Puls R; Carey D; Cunningham P; Kelleher A, 2015, 'Cerebrospinal fluid exposure of efavirenz and its major metabolites when dosed at 400 mg and 600 mg once daily: A randomized controlled trial', Clinical Infectious Diseases, 60, pp. 1026 - 1032, http://dx.doi.org/10.1093/cid/ciu976

Sharma S; Babiker A; Emery S; Gordin F; Lundgren J; Neaton J; Bakowska E; Schechter M; Wiselka M; Wolff M, 2015, 'Demographic and HIV-specific characteristics of participants enrolled in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial', HIV Medicine, 16, pp. 30 - 36, http://dx.doi.org/10.1111/hiv.12231

Lundgren J; Babiker A; Gordin F; Emery S; Fätkenheuer G; Molina JM; Wood R; Neaton JD; Agan BK; Alston-Smith B; Arenas-Pinto A; Arribas JR; Baker JV; Baxter J; Belloso WH; Brekke K; Brew B; Brobst SW; Burman W; Carey C; Clark R; Cooper DA; Davey RT; De La Rosa G; Denning ET; Dolan M; Dore G; Duprez D; Emanuel E; Grady C; Grund B; Hirschel B; Hoen B; Hudson F; Johnson MA; Kambili C; Klingman K; Kunisaki KM; Landay A; Ledergerber B; Lehrman SN; Martinez A; Meger S; Misar K; Mitsuyasu RT; Mocroft A; Munroe D; Norton M; Palmer RC; Pett SL; Phillips A; Pillay D; Porter D; Price RW; Proschan M; Rappoport C; Reiss P; Renjifo B; Robertson K; Rockstroh J; Rodriguez G; Rooney JF; Ross MJ; Schechter M; Schwarze S; Seekins D; Sharma S; Snowden W; Telenti A; Tryon J; van Wyk J; Vjecha MJ; Wright E; Cooper D, 2015, 'Why START? Reflections that led to the conduct of this large long-term strategic HIV trial', HIV Medicine, 16, pp. 1 - 9, http://dx.doi.org/10.1111/hiv.12227

Winston A; Puls R; Kerr SJ; Duncombe C; Li P; Gill JM; Ramautarsing R; Taylor-Robinson SD; Emery S; Cooper DA; Belloso W; Gazzard B; Hung CC; Jessen H; Kamrulazaman A; Li L; Losso M; Sierra-Madero J; Mallon P; Mason B; Molina JM; Petoumenos K; Phanuphak P; Pollack S; Rooney J; Walmsley S; Wolff M, 2015, 'Differences in the direction of change of cerebral function parameters are evident over three years in HIV-infected individuals electively commencing initial cART', PLoS ONE, 10, pp. e0118608, http://dx.doi.org/10.1371/journal.pone.0118608

Amin J; Boyd MA; Kumarasamy N; Moore CL; Losso MH; Nwizu CA; Mohapi L; Kerr SJ; Sohn AH; Teppler H; Renjifo B; Molina JM; Emery S; Cooper DA, 2015, 'Raltegravir non-inferior to nucleoside based regimens in second-line therapy with lopinavir/ritonavir over 96 weeks: A randomised open label study for the treatment of HIV-1 infection', PLoS ONE, 10, pp. e0118228, http://dx.doi.org/10.1371/journal.pone.0118228

Boyd MA; Moore CL; Molina JM; Wood R; Madero JS; Wolff M; Ruxrungtham K; Losso M; Renjifo B; Teppler H; Kelleher AD; Amin J; Emery S; Cooper DA, 2015, 'Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: An exploratory analysis', The Lancet HIV, 2, pp. e42 - e51, http://dx.doi.org/10.1016/S2352-3018(14)00061-7

Achhra AC; Phillips A; Emery S; Macarthur RD; Furrer H; De Wit S; Losso M; Law MG; Han A, 2015, 'Pre-therapy inflammation and coagulation activation and long-term CD4 count responses to the initiation of antiretroviral therapy', HIV Medicine, 16, pp. 449 - 454, http://dx.doi.org/10.1111/hiv.12258

, 2015, '8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015).', J Int AIDS Soc, 18, pp. 20479, http://dx.doi.org/10.7448/IAS.18.5.20479

Bavinton BR; Jin F; Prestage G; Zablotska I; Koelsch KK; Phanuphak N; Grinsztejn B; Cooper DA; Fairley C; Kelleher A; Triffitt K; Grulich AE; Templeton D; Emery S, 2014, 'The Opposites Attract Study of viral load, HIV treatment and HIV transmission in serodiscordant homosexual male couples: Design and methods', BMC Public Health, 14, pp. 917, http://dx.doi.org/10.1186/1471-2458-14-917

Borges AH; Weitz JI; Collins G; Baker JV; Lévy Y; Davey RT; Phillips AN; Neaton JD; Lundgren JD; Deeks SG, 2014, 'Markers of inflammation and activation of coagulation are associated with anaemia in antiretroviral-treated HIV disease', AIDS, 28, pp. 1791 - 1796, http://dx.doi.org/10.1097/QAD.0000000000000344

Lynfield R; Davey R; Dwyer DE; Losso MH; Wentworth D; Cozzi-Lepri A; Herman-Lamin K; Cholewinska G; David D; Kuetter S; Ternesgen Z; Uyeki TM; Lane HC; Lundgren J; Neaton JD, 2014, 'Outcomes of influenza A(H1N1)pdm09 virus infection: Results from two international cohort studies', PLoS ONE, 9, http://dx.doi.org/10.1371/journal.pone.0101785

Nordell AD; McKenna M; Borges AH; Duprez D; Neuhaus J; Neaton JD, 2014, 'Severity of Cardiovascular Disease Outcomes Among Patients With HIV Is Related to Markers of Inflammation and Coagulation', JOURNAL OF THE AMERICAN HEART ASSOCIATION, 3, http://dx.doi.org/10.1161/JAHA.114.000844

Cummins NW; Neuhaus J; Sainski AM; Strausbauch MA; Wettstein PJ; Lewin SR; Plana M; Rizza SA; Temesgen Z; Touloumi G; Freiberg M; Neaton J; Badley AD, 2014, 'Short communication: CD4 T cell declines occurring during suppressive antiretroviral therapy reflect continued production of Casp8p41', AIDS Research and Human Retroviruses, 30, pp. 476 - 479, http://dx.doi.org/10.1089/aid.2013.0243

Miller CJ; Baker JV; Bormann AM; Erlandson KM; Hullsiek KH; Justice AC; Neuhaus J; Paredes R; Petoumenos K; Wentworth D; Winston A; Wolfson J; Neaton JD; Emery S, 2014, 'Adjudicated morbidity and mortality outcomes by age among individuals with HIV infection on suppressive antiretroviral therapy', PLoS ONE, 9, pp. e95061, http://dx.doi.org/10.1371/journal.pone.0095061

Haskelberg H; Pocock N; Amin J; Ebeling PR; Emery S; Carr A; Post J; Medland N; Boyd M, 2014, 'Hip structural parameters over 96 weeks in HIV-infected adults switching treatment to tenofovir-emtricitabine or abacavir-lamivudine', PLoS ONE, 9, pp. e94858, http://dx.doi.org/10.1371/journal.pone.0094858

Revell AD; Wang D; Wood R; Morrow C; Tempelman H; Hamers R; Alvarez-Uria G; Streinu-Cercel A; Ene L; Wensing A; Reiss P; van Sighem AI; Nelson M; Emery S; Montaner JSG; Lane HC; Larder BA; Reiss P; van Sighem A; Montaner J; Harrigan R; Rinke de Wit T; Hamers R; Sigaloff K; Agan B; Marconi V; Wegner S; Sugiura W; Zazzi M; Streinu-Cercel A; Alvarez-Uria G; Gatell J; Lazzari E; Gazzard B; Nelson M; Pozniak A; Mandalia S; Ruiz L; Clotet B; Staszewski S; Torti C; Lane C; Metcalf J; Perez-Elias M-J; Carr A; Norris R; Hesse K; Vlahakis E; Tempelman H; Barth R; Morrow C; Wood R; Ene L; Dragovic G; Cooper D; Torti C; Baxter J; Monno L; Torti C; Gatell J; Clotet B; Picchio G; deBethune M-P; Perez-Elias M-J, 2014, 'An update to the HIV-TRePS system: the development of new computational models that do not require a genotype to predict HIV treatment outcomes', Journal of Antimicrobial Chemotherapy, 69, pp. 1104 - 1110, http://dx.doi.org/10.1093/jac/dkt447

Haskelberg H; Cordery DV; Amin J; Kelleher AD; Cooper DA; Emery S; Post J, 2014, 'HLA Alleles association with changes in bone mineral density in HIV-1-infected adults changing treatment to tenofovir-emtricitabine or abacavir-lamivudine', PLoS ONE, 9, pp. e93333, http://dx.doi.org/10.1371/journal.pone.0093333

Borges AH; O'Connor JL; Phillips AN; Baker JV; Vjecha MJ; Losso MH; Klinker H; Lopardo G; Williams I; Lundgren JD, 2014, 'Factors associated with D-dimer levels in HIV-infected individuals', PLoS ONE, 9, http://dx.doi.org/10.1371/journal.pone.0090978

Lucas GM; Cozzi-Lepri A; Wyatt CM; Post FA; Bormann AM; Crum-Cianflone NF; Ross MJ, 2014, 'Glomerular filtration rate estimated using creatinine, cystatin C or both markers and the risk of clinical events in HIV-infected individuals', HIV Medicine, 15, pp. 116 - 123, http://dx.doi.org/10.1111/hiv.12087

Revell AD; Boyd MA; Wang D; Emery S; Gazzard B; Reiss P; van Sighem A; Montaner JS; Lane HC; Larder BA, 2014, 'A comparison of computational models with and without genotyping for prediction of response to second-line HIV therapy', HIV Medicine, 15, pp. 442 - 448, http://dx.doi.org/10.1111/hiv.12156

Peters L; Neuhaus J; Duprez D; Neaton JD; Tracy R; Klein MB; Mocroft A; Rockstroh J; Dore G; Lundgren JD; Emery S, 2014, 'Biomarkers of inflammation, coagulation and microbial translocation in HIV/HCV co-infected patients in the SMART study', Journal of Clinical Virology, 60, pp. 295 - 300, http://dx.doi.org/10.1016/j.jcv.2014.03.017

Haskelberg H; Mallon PWG; Hoy J; Amin J; Moore C; Phanuphak P; Ferret S; Belloso WH; Boyd MA; Cooper DA; Emery S, 2014, 'Bone mineral density over 96 weeks in adults failing first-line therapy randomized to raltegravir/lopinavir/ ritonavir compared with standard second-line therapy', Journal of Acquired Immune Deficiency Syndromes, 67, pp. 161 - 168, http://dx.doi.org/10.1097/QAI.0000000000000288

Amin J; Law MG; Puls R; Kelleher A; Cooper DA; Emery S; Han A, 2014, 'Comparison of central and local HIV-1 RNA quantification from two international clinical trials', AIDS, 28, pp. 2480 - 2483, http://dx.doi.org/10.1097/QAD.0000000000000461

Dawood FZ; Roediger MP; Grandits G; Miller D; Fisher M; Zhang ZM; Hodder S; Hoy JF; Lundgren JD; Neaton JD; Soliman EZ, 2014, 'Determinants of developing widened spatial QRS-T angle in HIV-infected individuals: Results from the Strategies for Management of Antiretroviral Therapy [SMART] Study', Journal of Electrocardiology, 47, pp. 264 - 271, http://dx.doi.org/10.1016/j.jelectrocard.2013.12.001

Amin J; Becker S; Belloso W; Boffito M; Cooper D; Crabtree-Ramirez B; Duncombe C; Emery S; Foulkes S; Hill A; Jessen H; Kumar S; Lee MP; Losso M; Nwizu C; Phanuphak P; Ripin D; Read T; Rooney J; Schaffer K; Shahar E; Winston A; Wolff M; Young B; Abela C; Boyd M; Carey D; Clarke A; Courtney-Vega K; Dazo C; Delfino M; Donaldson A; Espinosa N; Johannesen T; Kaew-On P; Lin E; Moricz A; Taylor J; Phanupak P; Puls RL; Pussadee K; Sutheerasak P; Tomkins L; Ubolyam S; Shah Bin Raja Azwa RI; Bissio E; Calanni L; Casiro A; Chetchotisakd P; Contarelli J; Doong N; Elliott J; Gazzard B; Kelly M; Del Carmen Luna N; Lupo S; Messina OG; Mohapi L; Moore R; Nolan D; Orrell C; Perez C; Pett S; Rockstroh J; Supparatpinyo K; Smith D; Villanueva JA; Vlahakis E; Kelleher T; Cunningham P; Merlin K; Yeung J; Shaik A; Fsadni B; Carrera A; Lograsso M; Gulick R; Crabtree-Ramiraz B; Winston E; Dunn D; Dolan M; Cooper D; Kelleher A, 2014, 'Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): A randomised, double-blind, placebo-controlled, non-inferiority trial', The Lancet, 383, pp. 1474 - 1482, http://dx.doi.org/10.1016/S0140-6736(13)62187-X

Murray JM; Zaunders JJ; McBride KL; Xu Y; Bailey M; Suzuki K; Cooper DA; Emery S; Kelleher AD; Koelsch KK, 2014, 'HIV DNA subspecies persist in both activated and resting memory CD4⁺ T cells during antiretroviral therapy', Journal of Virology, 88, pp. 3516 - 3526, http://dx.doi.org/10.1128/JVI.03331-13

Dooko CBA; De Wit S; Neuhaus J; Palfreeman A; Pepe R; Pankow JS; Neaton JD, 2014, 'Interleukin-6, high sensitivity C-reactive protein, and the development of type 2 diabetes among HIV-positive patients taking antiretroviral therapy', Journal of Acquired Immune Deficiency Syndromes, 67, pp. 538 - 546, http://dx.doi.org/10.1097/qai.0000000000000354

Murray JM; Zaunders JJ; Koelsch KK; Natarajan V; Badralmaa Y; McBride K; Carrera A; Cooper DA; Emery S; Kelleher AD, 2013, 'Short communication: HIV blips while on antiretroviral therapy can indicate consistently detectable viral levels due to assay underreporting', AIDS Research and Human Retroviruses, 29, pp. 1621 - 1625, http://dx.doi.org/10.1089/aid.2013.0132

Martin A; Moore C; Mallon PWG; Hoy J; Emery S; Belloso W; Phanuphak P; Ferret S; Cooper DA; Boyd MA, 2013, 'Bone mineral density in HIV participants randomized to raltegravir and lopinavir/ritonavir compared with standard second line therapy', AIDS, 27, pp. 2403 - 2411, http://dx.doi.org/10.1097/01.aids.0000432534.47217.b4

Grund B; Wright EJ; Brew BJ; Price RW; Roediger MP; Bain MP; Hoy JF; Shlay JC; Vjecha MJ; Robertson KR, 2013, 'Improved neurocognitive test performance in both arms of the SMART study: Impact of practice effect', Journal of NeuroVirology, 19, pp. 383 - 392, http://dx.doi.org/10.1007/s13365-013-0190-x

Rotger M; Glass TR; Junier T; Lundgren J; Neaton JD; Poloni ES; Van 'T Wout AB; Lubomirov R; Colombo S; Martinez R; Rauch A; Günthard HF; Neuhaus J; Wentworth D; Van Manen D; Gras LA; Schuitemaker H; Albini L; Torti C; Jacobson LP; Li X; Kingsley LA; Carli F; Guaraldi G; Ford ES; Sereti I; Hadigan C; Martinez E; Arnedo M; Egaña-Gorroño L; Gatell JM; Law M; Bendall C; Petoumenos K; Rockstroh J; Wasmuth JC; Kabamba K; Delforge M; De Wit S; Berger F; Mauss S; De Paz Sierra M; Losso M; Belloso WH; Leyes M; Campins A; Mondi A; De Luca A; Bernardino I; Barriuso-Iglesias M; Torrecilla-Rodriguez A; Gonzalez-Garcia J; Arribas JR; Fanti I; Gel S; Puig J; Negredo E; Gutierrez M; Domingo P; Fischer J; Fätkenheuer G; Alonso-Villaverde C; MacKen A; Woo J; McGinty T; Mallon P; Mangili A; Skinner S; Wanke CA; Reiss P; Weber R; Bucher HC; Fellay J; Telenti A; Tarr PE, 2013, 'Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons', Clinical Infectious Diseases, 57, pp. 112 - 121, http://dx.doi.org/10.1093/cid/cit196

O'Connor JL; Gardner EM; Mannheimer SB; Lifson AR; Esser S; Telzak EE; Phillips AN, 2013, 'Factors associated with adherence amongst 5295 people receiving antiretroviral therapy as part of an international trial', Journal of Infectious Diseases, 208, pp. 40 - 49, http://dx.doi.org/10.1093/infdis/jis731

Byakwaga H; Petoumenos K; Ananworanich J; Zhang F; Boyd MA; Sirisanthana T; Li PCK; Lee C; Mean CV; Saphonn V; Omar SFS; Pujari S; Phanuphak P; Lim PL; Kumarasamy N; Chen YMA; Merati TP; Sungkanuparph S; Ditangco R; Oka S; Tau G; Zhou J; Law MG; Emery S; Han A, 2013, 'Predictors of clinical progression in HIV-1-infected adults initiating combination antiretroviral therapy with advanced disease in the Asia-Pacific region: Results from the TREAT Asia HIV Observational Database', Journal of the International Association of Providers of AIDS Care, 12, pp. 270 - 277, http://dx.doi.org/10.1177/1545109712469684

Kent SJ; Reece JC; Petravic J; Martyushev A; Kramski M; De Rose R; Cooper DA; Kelleher AD; Emery S; Cameron PU; Lewin SR; Davenport MP, 2013, 'The search for an HIV cure: Tackling latent infection', The Lancet Infectious Diseases, 13, pp. 614 - 621, http://dx.doi.org/10.1016/S1473-3099(13)70043-4

Borges AH; Silverberg MJ; Wentworth D; Grulich AE; Fätkenheuer G; Mitsuyasu R; Tambussi G; Sabin CA; Neaton JD; Lundgren JD, 2013, 'Predicting risk of cancer during HIV infection: The role of inflammatory and coagulation biomarkers', AIDS, 27, pp. 1433 - 1441, http://dx.doi.org/10.1097/QAD.0b013e32835f6b0c

Andrade BB; Hullsiek KH; Boulware DR; Rupert A; French MA; Ruxrungtham K; Montes ML; Price H; Barreiro P; Audsley J; Sher A; Lewin SR; Sereti I, 2013, 'Biomarkers of inflammation and coagulation are associated with mortality and hepatitis flares in persons coinfected with HIV and hepatitis viruses', Journal of Infectious Diseases, 207, pp. 1379 - 1388, http://dx.doi.org/10.1093/infdis/jit033

Gupta M; Miller CJ; Baker JV; Lazar J; Bogner JR; Calmy A; Soliman EZ; Neaton JD, 2013, 'Biomarkers and electrocardiographic evidence of myocardial ischemia in patients with human immunodeficiency virus infection', American Journal of Cardiology, 111, pp. 760 - 764, http://dx.doi.org/10.1016/j.amjcard.2012.11.032

Dawood FZ; Khan F; Roediger MP; Zhang ZM; Swaminathan S; Klinker H; Hoy J; Lundgren JD; Neaton JD; Soliman EZ, 2013, 'Electrocardiographic spatial QRS-T angle and incident cardiovascular disease in hiv-infected patients (from the Strategies for the Management of Antiretroviral Therapy [SMART] Study)', American Journal of Cardiology, 111, pp. 118 - 124, http://dx.doi.org/10.1016/j.amjcard.2012.08.054

Martin A; Moore CL; Mallon PWG; Hoy JF; Emery S; Belloso WH; Phanuphak P; Ferret S; Cooper DA; Boyd MA; Second-Line Study Team , 2013, 'HIV lipodystrophy in participants randomised to lopinavir/ritonavir (LPV/r) +2-3 nucleoside/nucleotide reverse transcriptase inhibitors (N(t)RTI) or LPV/r + raltegravir as second-line antiretroviral therapy.', PloS one, 8, http://dx.doi.org/10.1371/journal.pone.0077138

Back to profile page